{"version":"1.0","type":"link","title":"Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Early-Stage Breast Cancer with Preserved Baseline LVEF: Incidence of Cardiotoxicity and Feasibility of Simplified Cardiac Surveillance.","author_name":"Tsunoda A 외","author_url":"https://prs-insight.online/author/Tsunoda%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/76646","thumbnail_width":1200,"thumbnail_height":630}